1. Home
  2. LYEL vs MSC Comparison

LYEL vs MSC Comparison

Compare LYEL & MSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$12.77

Market Cap

320.1M

Sector

Health Care

ML Signal

HOLD

Logo Studio City International Holdings Limited

MSC

Studio City International Holdings Limited

HOLD

Current Price

$1.83

Market Cap

352.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYEL
MSC
Founded
2018
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
320.1M
352.4M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
LYEL
MSC
Price
$12.77
$1.83
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$30.60
N/A
AVG Volume (30 Days)
230.3K
2.3K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8,712.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.28
$1.58
52 Week High
$45.00
$6.63

Technical Indicators

Market Signals
Indicator
LYEL
MSC
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
LYEL
MSC

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.

About MSC Studio City International Holdings Limited

Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.

Share on Social Networks: